Cargando…
Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL(pro)
The COVID-19 has now been declared a global pandemic by the World Health Organization. No approved drug is currently available; therefore, an urgent need has been developed for any antiviral therapy for COVID-19. Main protease 3CL(pro) of this novel Coronavirus (SARS-CoV-2) play a critical role in t...
Autores principales: | Vincent, Savariar, Arokiyaraj, Selvaraj, Saravanan, Muthupandian, Dhanraj, Manoj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785853/ https://www.ncbi.nlm.nih.gov/pubmed/33425994 http://dx.doi.org/10.3389/fmolb.2020.613401 |
Ejemplares similares
-
Antidiabetic activity of Kabasura Kudineer Chooranam
por: Harini, P., et al.
Publicado: (2022) -
Molecular docking analysis of potential compounds from an Indian medicinal soup "kabasura kudineer" extract with IL-6
por: Saleem Basha, S, et al.
Publicado: (2021) -
In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein
por: Kiran, Gangarapu, et al.
Publicado: (2022) -
Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives
por: Vivekanandhan, Karthik, et al.
Publicado: (2021) -
Effectiveness of Kabasura Kudineer tablets in the management of asymptomatic and mild cases of COVID-19: A pilot double-blinded, randomized controlled trial
por: Khapre, Minakshi, et al.
Publicado: (2023)